Fennel

Fennel (Foeniculum vulgare Mill.): A Comprehensive Reference

1. Identity and Botanical Classification

1.1 Nomenclature and Taxonomy

Foeniculum vulgare Mill., known in English as fennel and as Fenouil in French, belongs to the Apiaceae family. The genus name Foeniculum is derived from the Latin word foenum, meaning "hay," referring to the plant's fragrant, dried foliage. The species epithet vulgare simply means "common." The genus Foeniculum contains only one species, Foeniculum vulgare, which has several varieties, including sweet fennel and bitter fennel. Foeniculum is classified botanically into two sub-species: piperitum and vulgare.

Fennel is a cuisine spice of the Apiaceae genus extensively cultivated in tropical and temperate regions. It is a 1 to 2-meter tall, herbaceous, and fragrant plant that is found throughout Asia, the Mediterranean, and many regions of Europe. This perennial herb is characterized by its feathery, blue-green leaves, yellow flowers, and a bulbous base. Fennel is native to the Mediterranean, but is now found throughout the world.

1.2 Plant Parts and Common Preparations

Every part of the fennel plant has documented use. While fennel seeds are most commonly used in herbalism, every part of fennel — from the bulb (technically not a bulb, but enlarged, overlapping petioles or bases of the leaves) and stem to leaf and seed — has found its way into culinary and medicinal use around the world.

Common preparations include:

• Dried fruits (seeds): Used as flavourings in baked goods, meat and fish dishes, ice cream, alcoholic beverages, and herb mixtures.
• Essential oil: Steam-distilled from the dried fruits; the most pharmacologically studied preparation.
• Infusion/tea: Prepared by steeping crushed or powdered dried fruit in hot water.
• Vaginal/topical creams: Used in clinical trials for menopausal and dermatological applications.
• Oral drop solutions: Standardized preparations used in dysmenorrhea clinical studies.
• Seed powder capsules: Used in galactagogue and other studies.

Foeniculum vulgare is widely used as a carminative, digestive, lactogogue, and diuretic, and in treating respiratory and gastrointestinal disorders. Foeniculum vulgare is officially noted in the Ayurvedic Pharmacopoeia as an important part of polyherbal formulations in the treatment of different diseases and disorders.

2. Traditional and Historical Use

2.1 Ancient Mediterranean Civilizations

Fennel was an important plant cultivated by the ancient Egyptians, Romans, Indians, and Chinese. In early Sanskrit writings in India, fennel was known as madhurika, and its cultivation in India dates back to at least 2000 BC.

Fennel appears in the most ancient Greek medical literature that has been preserved — the writings attributed to the Father of Medicine, Hippocrates (5th/4th century BCE). In this series of texts, fennel is mentioned in no less than 30 formulae for medicines. Characteristically, almost all are in the oldest works of the Hippocratic Collection, which are devoted to gynecology. Hippocrates and Dioscorides described fennel as a diuretic and emmenagogue and used it to strengthen eyesight.

To the ancient Greeks, fennel represented success and was called marathon because the battle of Marathon (490 BC) was fought in a fennel field. Fennel was also a triumph symbol for the Romans, and leaves were used to crown winners of games. Pliny the Elder, the Roman author of Naturalis Historia, believed that serpents ate and rubbed against fennel because it was able to improve their eyesight after shedding their skins.

Emperor Charlemagne required the cultivation of fennel on all imperial farms. In medieval times, fennel was employed, together with St. John's Wort and other herbs, as a preventative of witchcraft and other evil influences, being hung over doors on Midsummer's Eve to ward off evil spirits.

2.2 Traditional Chinese Medicine

Fennel is also featured in the 16th-century Chinese Materia Medica for its use in traditional medicine. In Traditional Chinese Medicine, practitioners used fennel as a warming herb to help maintain digestive health.

2.3 Ayurvedic Tradition

In India, Ayurvedic healers praised fennel for its ability to balance the three body types, or doshas. Its Sanskrit name madhurika is referenced in early writings, with cultivation documented from at least 2000 BC.

2.4 Iranian (Persian) Traditional Medicine

In Iranian Traditional Medicine, fennel was known as "Razaianeh," "Razianaj," "Badian," and "Marsoun." According to Iranian traditional beliefs, fennel with hot and dry nature was used as a galactagogue, diuretic, emmenagogue, mucolytic, and lithontriptic agent. Fennel was regarded as an effective remedy for visual acuity, cataract, stomachache, chronic diarrhea, nausea, vomiting, chronic fever, kidney stones, internal obstructions, and urinary diseases.

2.5 Traditional Medicinal Applications Across Cultures

Fennel was used in the Greek, Indian, Arabic, and Iranian traditional systems of alternative medicine. Different parts of the plant were employed to treat many digestive ailments, diabetes, bronchitis, chronic cough, kidney stones, eye strain and irritation, and to improve eyesight. Intestinal bacteria and hookworm were expelled using tea prepared with fennel seeds and leaves. Due to its diuretic effect, fennel was also used to treat kidney and bladder diseases, and to relieve nausea. It has been used as a galactagogue for improving the milk supply of a breastfeeding mother, and fennel water was used to alleviate colic of infants.

Fennel has been used in traditional medicine for a wide range of ailments related to digestive, endocrine, reproductive, and respiratory systems. It has been used for more than forty types of disorders.

3. Key Constituents and Active Compounds

3.1 Volatile Essential Oil

Phenols, phenolic glycosides, and volatile aroma compounds such as trans-anethole, estragole, and fenchone have been reported as the major phytoconstituents of this species.

The essential oil composition varies substantially by cultivar, plant part, and maturity stage. In sweet fennel fruit oil: the fenchone content usually does not exceed 5%, whereas in the bitter types its content can be as high as 20%. In sweet fennel oil, the anethole content reaches 84–90%, whereas its proportion in bitter fennel is about 61–70%. Overall, the volatile oil is a mixture of many different constituents; the main ingredients are: anethole (40–70%), fenchone (1–20%), and estragole (2–9%).

Specific analyses of fennel essential oil in the literature reveal its dominant constituents. One analysis identified trans-anethole (72.2%) as the principal compound, followed by estragole (7.6%), d-limonene (6.8%), and fenchone (3.9%). The major components of fennel are phenylpropanoid derivatives: trans-anethole and estragole (= methyl chavicol), and then alpha-phellandrene, limonene, fenchone, and alpha-pinene. Other minor constituents may be present including R-pinene, β-pinene, β-myrcene, and p-cymene.

Composition also varies between plant parts: estragole (methyl chavicol) has been determined as the main component of leaf (51.7%), flower (38.9%), and seed (53.3%) essential oils, while fenchyl acetate (35.3%) was the dominant component in the stem essential oil.

Essential oil composition depends upon internal and external factors affecting the plant, such as genetic structure and ecological conditions; agricultural practices also have critical effects on yield and oil composition in the essential oil crops.

3.2 Non-Volatile Phytochemicals

Phytochemical studies have shown the presence of numerous valuable compounds, such as volatile compounds, flavonoids, phenolic compounds, fatty acids, and amino acids. Fennel fruits contain carbohydrates, alkaloids, phytosterols, phenols, tannins, and flavonoids. They are also a rich source of dietary fiber, protein, calcium, iron, magnesium, and manganese.

Beyond anethole, fennel seeds also contain flavonoids including quercetin and kaempferol — compounds with demonstrated anti-inflammatory and antioxidant activity — alongside fenchone, estragole, and a range of phenolic acids that contribute to its broad biological activity.

3.3 Trans-Anethole: The Primary Bioactive Compound

Trans-anethole is the dominant and most thoroughly studied constituent of fennel essential oil. Trans-anethole (p-methoxypropenylobenzene) is an organic compound, a by-product of terpene synthesis. It constitutes the major ingredient of essential oils from anise, star anise, and fennel. Existing evidence demonstrates its antimicrobial, insecticidal, larvicidal, and antioxidative properties.

At the molecular level, research has demonstrated trans-anethole's activity at TRPA1 ion channels: TRPA1 is a target of trans-anethole in fennel oil and fennel seed extract. Similar to the full oil, trans-anethole selectively elicited calcium influx in TRPA1-expressing mouse sensory neurons of the dorsal root and trigeminal ganglia. These fennel oil- and anethole-induced calcium responses were blocked by a selective TRPA1 channel antagonist. Trans-anethole is characterized as a selective, nonelectrophilic, and seemingly less-irritating agonist of TRPA1.

4. Mechanisms of Action

4.1 Antispasmodic Action

The antispasmodic mechanism involves direct interaction with voltage-gated L-type calcium channels, which reduces intracellular calcium concentration and prevents the calcium-calmodulin complex from activating myosin light chain kinase — the enzyme that triggers smooth muscle contraction. Multiple in vitro studies confirm fennel extract's ability to inhibit acetylcholine-induced and histamine-induced smooth muscle contractions in isolated intestinal tissue preparations. This antispasmodic action complements the carminative effect, making fennel particularly valuable for digestive complaints accompanied by cramping pain.

4.2 Phytoestrogenic Activity

The phytoestrogenic effect is attributed to the properties of trans-anethole and its polymer compounds (dianethole and photoanethole), which mimic the action of estrogen at estrogen receptors. The main chemical compounds of fennel include trans-anethole and di-anethole, along with their estrogenic effects. This action is significantly weaker than endogenous estrogen or pharmaceutical estrogens but may contribute to fennel's traditional uses for menstrual regulation, menopausal symptom relief, and lactation support.

4.3 Prostaglandin Inhibition and Uterine Effects

Fennel oil inhibited the response of the uterus to oxytocin and prostaglandin E2 by reducing its contraction frequency and intensity. The mechanism of action of fennel oil is similar to diclofenac, which has a direct effect on uterine smooth muscle and the central nervous system. Anethole, as the main component of fennel oil, has a similar structure to dopamine, which binds to dopamine receptors and decreases pain.

At concentrations of 10, 20, and 40 μg/mL, fennel oil revealed a significant inhibitory effect against prostaglandin E2. Fennel oil significantly reduced the frequency of uterine contraction induced by prostaglandin E2.

4.4 Antioxidant Activity

Antioxidant activity of fennel essential oils has been evaluated by several complementary tests including DPPH free radical scavenging, FRAP assay, and TBARS assay. Two of the fennel cultivars showed dramatically higher antioxidant activities, and these were similar in that trans-anethole was the major component in each oil.

4.5 Antimicrobial Activity

Pharmacologically, the fruits possess antioxidant, anti-inflammatory, antispasmodic, diuretic, antihypertensive, antimicrobial, gastroprotective, estrogenic, hepatoprotective, and antithrombotic activities. The most important chemical components of the essential oils — trans-anethole, estragole, fenchone, and α-phellandrene — have many applications in the food, pharmaceutical, and health sectors. These essential oils have anti-hypertensive, anti-spasmodic, anti-inflammatory, blood pressure lowering, and analgesic properties.

5. Scientific Evidence by Health Area

5.1 Digestive System: Infantile Colic

Fennel is a culinary and folk medicinal plant used worldwide in infantile colic, bloating, and indigestion, but has scarce scientific evidence.

Key clinical evidence: In a double-blind, randomized, placebo-controlled trial, fennel oil treatment eliminated infantile colic in 65% of patients, compared to 23.7% in the placebo group. This landmark trial (Alexandrovich et al., 2003) used a 0.1% fennel seed oil emulsion as its intervention.

Significant reductions in colic episodes and crying time were reported in two studies on fennel (seed oil or tea), and in three studies on different multiple herbal extracts (all including fennel). A systematic review and meta-analysis noted that evidence was found for effectiveness for different fennel preparations (e.g., oil, tea, herbal compound) in treating children with infantile colic, but the authors confirmed the need for further clinical studies to demonstrate efficacy and safety.

Evidence strength: Moderate. Multiple small RCTs show positive signals. Safety regulators have raised concerns about estragole exposure in infants at pharmacological doses (see Section 7), tempering enthusiasm for routine clinical recommendation.

5.2 Digestive System: Irritable Bowel Syndrome (IBS)

In adult patients, some publications report the use of fennel in irritable bowel syndrome (IBS).

Key clinical evidence: In a clinical trial published in the Annals of Gastroenterology, patients taking a combination of fennel oil and turmeric extract saw a 29% reduction in IBS severity scores after just 30 days, with further improvement continuing through a 60-day follow-up period. Quality of life improved by an average of 31% over the two months. Patients with diarrhea-predominant IBS saw the most dramatic quality-of-life improvement at roughly 70%, compared to about 25% for those with constipation-predominant or mixed-type IBS.

A separate study by Di Ciaula et al. (2018) enrolled 211 individuals with IBS with diarrhea, IBS with constipation, and combined disease with IBS, who were treated with curcumin extract (42 mg) and fennel essential oil (25 mg) for 60 days.

Evidence strength: Preliminary to moderate. Most IBS trials combine fennel with curcumin or other agents, making it difficult to attribute all benefits to fennel alone; single-herb effects remain uncertain.

5.3 Reproductive Health: Primary Dysmenorrhea

Fennel is used as an alternative treatment for primary dysmenorrhea. Reviews aim to evaluate the effectiveness and safety of fennel for reducing pain in primary dysmenorrhea.

Key clinical evidence: Multiple randomized trials plus a systematic review suggest fennel can meaningfully reduce menstrual cramp pain compared with placebo in the first days of menses. Most data come from oral 1–2% drop solutions, taken every 6–8 hours for a few days. The pooled results of seven trials showed that the effect of fennel is similar to that of conventional drug therapies in alleviating pain (n = 502, standardized mean difference (SMD): 0.07).

The proposed mechanism is well-defined: although the main reason for primary dysmenorrhea is not fully established, the accepted theory is the overproduction of endometrial prostaglandins. Ovarian steroids, pituitary prostaglandins, and cervical obstruction are the main reasons for uterine hyperactivity. Prostaglandins constrict the uterine smooth muscle and cause colic pains; therefore, a drug with antispasmodic action is an effective treatment for reducing pain. Fennel oil inhibited the response of the uterus to oxytocin and prostaglandin E2 by reducing its contraction frequency and intensity.

Evidence strength: Moderate. Multiple small RCTs support efficacy comparable to non-steroidal anti-inflammatory drugs in some studies. Overall trial quality and sample sizes are modest; further large trials are warranted.

5.4 Women's Health: Menopause and Vaginal Atrophy

Phytoestrogens, as polyphenolic and nonsteroidal compounds in plants, can bind to human estrogen receptors; the effects of these compounds are less significant than those of endogenous steroidal estrogens. Based on in vivo and in vitro investigations, fennel, as a phytoestrogen, may treat several disorders including anxiety, depression, stress, sleep disorders, and vaginal atrophy.

Key clinical evidence: According to results of one study, fennel is an effective means to manage the symptoms of vaginal atrophy in postmenopausal women and is devoid of side effects. Topical and vaginal fennel extract (5%) exhibited good efficacy in treatment of sexual function, vaginal atrophy, and hirsutism. However, results across studies are inconsistent: fennel had no effect on bone density or body mass index of menopausal women.

The efficacy of oral fennel oil in management of dysmenorrhea, premenstrual syndrome, amenorrhea, menopause, lactation, and polycystic ovary syndrome has been confirmed according to results of clinical studies. However, larger studies are necessary to confirm the positive impact of fennel for vaginal atrophy.

Evidence strength: Preliminary. Individual small trials show promise for vaginal atrophy and menopausal symptoms. Studies note high placebo responses, and findings are not uniform across all menopausal outcomes.

5.5 Lactation (Galactagogue Effect)

Fennel has traditional use as a galactagogue to support breast milk production in nursing mothers. This effect is attributed to the phytoestrogenic properties of trans-anethole and its polymer compounds (dianethole and photoanethole), which mimic the action of estrogen at estrogen receptors. However, the estrogenic activity of fennel is relatively mild compared to pharmaceutical estrogens, and clinical evidence for galactagogue effects remains limited. A 2014 small clinical trial found that 500 mg/day of fennel seed powder increased breast milk volume in nursing mothers, though larger studies are needed.

Evidence strength: Preliminary. The traditional use is well-established across many cultures, and a mechanistic basis (phytoestrogenic activity) is plausible, but robust human trial evidence is lacking.

5.6 Antimicrobial Activity

Various pharmacological activities of fennel have been described including antioxidant, cytotoxic, anti-inflammatory, antimicrobial, bronchodilatory, estrogenic, diuretic, lithontripic, galactogogue, emmenagogue, antithrombotic, hypotensive, gastroprotective, hepatoprotective, memory enhancing, and antimutagenic activities.

Evidence strength: The antimicrobial activity of fennel essential oil is well-documented in laboratory (in vitro) models against numerous bacterial and fungal species, including S. aureus, E. coli, Candida albicans, and others. However, translation of these in vitro findings to clinical settings has not yet been established through human trials.

5.7 Hirsutism

A randomized placebo-controlled clinical trial evaluated topical fennel gel for hirsutism: the mean reduction of hair thickness was reported as 7.8%, 18.3%, and 0.5% for patients using 1% cream, 2% cream, and placebo, respectively. The best clinical response belonged to the group using 2% cream, with an effectiveness level of 18.3±8.3 for patients who received the cream containing fennel extract 2%. The mechanism of action is not fully clear, but may be due to anti-androgenic effects of trans-anethole and di-anethole.

Evidence strength: Preliminary. Small trial with positive signal; replication in larger studies required.

6. Body Systems and Health Areas

• Digestive system: Carminative, antispasmodic, and prokinetic effects; used for flatulence, bloating, dyspepsia, colic, and IBS.
• Reproductive and endocrine system: Emmenagogue, estrogenic effects; applications in dysmenorrhea, amenorrhea, PMS, menopausal symptoms, and vaginal atrophy.
• Lactation: Galactagogue; traditionally used to increase breast milk supply.
• Respiratory system: Traditional use for ailments related to respiratory systems. Historically used for bronchitis and chronic cough.
• Urinary system: Diuretic applications for kidney and bladder conditions, documented by Dioscorides and others.
• Skin and dermatology: Topical use for hirsutism and anti-inflammatory applications.
• Antimicrobial: In vitro activity against a broad range of bacteria and fungi.
• Cardiovascular: Antihypertensive and antithrombotic properties documented in preclinical models.

7. Dosage Forms and Dosages Reported in Clinical Studies

The following dosages are reported as they appeared in the cited studies and should not be taken as prescriptive recommendations:

• Infantile colic: A randomized trial used a 0.1% seed-oil emulsion to improve colic metrics over one week.
• IBS: One study used curcumin extract (42 mg) and fennel essential oil (25 mg) orally for 60 days.
• Primary dysmenorrhea: Multiple RCTs used oral 1–2% drop solutions taken every 6–8 hours for a few days during menstruation.
• Lactation: A small clinical trial used 500 mg/day of fennel seed powder.
• Vaginal atrophy: Topical and vaginal fennel extract at a concentration of 5% has been evaluated in clinical studies.
• Hirsutism: Topical creams at concentrations of 1% and 2% were tested, with the 2% cream showing the best clinical response.
• General infusion guidance: The main constituents of the volatile fraction of a fennel infusion prepared from dried fruit are trans-anethole (56.4–58.4%), fenchone (36.2–39.5%), and estragole (2.5–2.2%). Use of unbroken (uncrushed) fruit to prepare infusions is considered suboptimal, as crushed or powdered fruit gradually loses essential oil content during aging.

8. Safety, Toxicology, and Drug Interactions

8.1 General Safety Profile

No serious adverse events were recorded after ingestion of F. vulgare except some cases of allergic reactions. Fennel is generally well tolerated when used orally and topically. However, some common side effects may include gastrointestinal discomfort, photosensitivity, and allergic reactions in sensitive individuals. Serious adverse effects such as seizures are rare but have been reported in some cases.

8.2 Estragole: Genotoxicity and Carcinogenicity Concerns

The safety of estragole — a constituent of fennel essential oil — has been subject to formal evaluation by the European Medicines Agency (EMA) and the European Food Safety Authority (EFSA). A major example of naturally occurring genotoxic hepatocarcinogens is the alkenylbenzene estragole (1-allyl-4-methoxybenzene), a common component of spices and herbs. The carcinogenicity of estragole is attributable to the production of a reactive metabolite — the sulfate conjugate of 1′-hydroxy estragole — which is responsible for the production of liver DNA adducts. This bioactivation pathway has been shown in rodent studies where high doses of pure estragole were used.

The available toxicological data on estragole were thoroughly analysed by the Committee on Herbal Medicinal Products (HMPC) of the EMA. In its report, the Committee stated that the present exposure to estragole resulting from consumption of herbal medicinal products does not pose a significant risk. Rodent studies show that carcinogenic events are minimally probable in the dose range of 1–10 mg/kg body weight, which is approximately 100–1000 times the anticipated human exposure to estragole.

Nonetheless, regulatory bodies recommend minimizing exposure for vulnerable populations: the HMPC recommended minimizing exposure to estragole for sensitive groups such as young children, pregnant and breastfeeding women. Safety concerns were raised by the German Federal Institute for Risk Assessment (BfR) in relation to possible adverse effects associated with the consumption of fennel fruit preparations by infants and young children due to the presence of estragole, a known genotoxic carcinogen. An acceptable daily intake (ADI) for estragole could not be set, but a guidance value of 0.05 mg estragole per day for adults and adolescents and 1 µg estragole per kg bw per day for children was suggested. The EMA did not recommend the use of fennel fruit infusions in children up to the age of 4 years or the use of fennel fruit preparations in pregnant or lactating women due to limited data on the extent of potential adverse effects in these sub-populations.

Some researchers argue that studies of pure isolated estragole may overstate actual risk in the context of a complex herbal matrix: study of estragole as a single substance can be misleading and misrepresents the activity of this substance when present in the form of a complex herbal extract, bringing into question the validity of studies of pure compounds taken outside of the context of the normal food matrix.

8.3 Estrogenic Effects and Hormone-Sensitive Conditions

The estrogenic activity of F. vulgare brings some side effects such as decrease in protein concentration and acid and alkaline phosphatase in male genital organs, increase in weight of mammary glands and reproductive organs in women, and premature thelarche in girls. While no evidence of teratogenicity has been recorded, it is prudent not to use F. vulgare during pregnancy due to its estrogenic activity.

8.4 Neurotoxicity of Essential Oil

Ingestion of fennel's volatile oil may induce nausea, pulmonary edema, seizures, and vomiting. One case report describes a 28-year-old woman with well-controlled epilepsy who experienced a generalized tonic-clonic seizure, remaining unconscious for 45 minutes, following use of fennel essential oil. The oil's therapeutic use has occasionally induced epileptiform madness and hallucinations. This risk applies specifically to concentrated essential oil preparations, not to culinary or standard tea use.

8.5 Allergic Reactions and Cross-Reactivity

The principal hazards with fennel itself are photodermatitis and contact dermatitis. Some individuals exhibit cross-reactivity to several species of Apiaceae, characteristic of the "celery-carrot-mugwort-condiment" cross-reactivity syndrome. For those with known allergies to plants in the Apiaceae family — such as carrots or celery — fennel may cause an allergic reaction.

8.6 Drug Interactions

It has been demonstrated that F. vulgare inhibits cytochrome P450 3A4 (CYP3A4). Consequently, fennel may reduce the metabolism of several drugs that are primarily metabolized by this enzyme, which could alter their bioavailability and therapeutic efficacy. Specifically, one in vitro study suggests the constituent 5-methoxypsoralen contained in fennel has the ability to inhibit cytochrome P450 3A4. Therefore, cautious use of concomitant medications that require this isoenzyme as a substrate is warranted.

Other potential interactions documented in the literature include:

• Anticoagulants/antiplatelet drugs: Fennel may interact with certain drugs, particularly anticoagulant/antiplatelet drugs. Caution should be exercised when using fennel in combination with these medications.
• Hormonal medications: Fennel may reduce the effectiveness of hormonal contraceptives due to its phytoestrogenic properties.
• Antibiotics: Fennel may affect the absorption of certain antibiotics, such as ciprofloxacin.
• Epilepsy medications: Certain components in concentrated fennel essential oil have neurotoxic effects and can trigger seizures. For this reason, fennel essential oil is not recommended for individuals with epilepsy, as it could provoke a seizure even in a well-controlled patient.

Evidence for drug interactions is often limited and derived from in vitro or animal studies; caution is warranted with medications, particularly those with narrow therapeutic windows.

9. Evidence Summary and Characterization

Due to its commercial significance and considerable pharmaceutical industry uses, fennel is regarded as one of the world's most important medicinal plants while being one of the oldest spice plants. Findings based on traditional uses and scientific evaluation indicate that Foeniculum vulgare remains one of the most widely used herbal plants.

The overall body of evidence, as of the available literature, can be summarized as follows:

• Strongest evidence: Infantile colic (several RCTs with consistent positive results, though safety cautions apply for infants); primary dysmenorrhea (multiple RCTs and a systematic review supporting efficacy comparable to NSAIDs).
• Moderate/preliminary evidence: IBS (positive results from combination-product trials; single-herb evidence limited); vaginal atrophy and menopausal symptoms (small RCTs with inconsistent results); galactagogue use (mechanistic plausibility, limited clinical data).
• Preclinical/in vitro only: Anticancer, hepatoprotective, neuroprotective, and most antimicrobial claims — these require human clinical investigation before clinical conclusions can be drawn.

References

• Badgujar SB, Patel VV, Bandivdekar AH. Foeniculum vulgare Mill: A Review of Its Botany, Phytochemistry, Pharmacology, Contemporary Application, and Toxicology. BioMed Research International. 2014;2014:842674. PMC.
• Mirnezami M, et al. Medicinal properties of Foeniculum vulgare Mill. in traditional Iranian medicine and modern phytotherapy. PubMed 2013.
• Shahat AA, et al. Foeniculum vulgare: A comprehensive review of its traditional use, phytochemistry, pharmacology, and safety. Arabian Journal of Chemistry. 2012. ScienceDirect.
• Pharmacological, nutraceutical, functional and therapeutic properties of fennel (Foeniculum vulgare). International Journal of Food Properties. 2023. Taylor & Francis.
• Gori L, et al. Can Estragole in Fennel Seed Decoctions Really Be Considered a Danger for Human Health? A Fennel Safety Update. PMC. 2012.
• Mahboubi M. Foeniculum vulgare as Valuable Plant in Management of Women's Health. Journal of Menopausal Medicine. 2019. PMC.
• Javidnia K, et al. The effect of fennel (Foeniculum vulgare) gel 3% in decreasing hair thickness in idiopathic mild to moderate hirsutism, a randomized placebo controlled clinical trial. PMC. 2014.
• Takaishi M, et al. trans-Anethole of Fennel Oil is a Selective and Nonelectrophilic Agonist of the TRPA1 Ion Channel. PMC. 2019.
• Badawy MEI, et al. Chemical Composition, Antimicrobial and Antioxidant Activities of Essential Oils from Organically Cultivated Fennel Cultivars. PMC. 2018.
• Chemical Profiles and Antimicrobial Activities of Essential Oil From Different Plant Parts of Fennel (Foeniculum vulgare Mill.). PMC. 2025.
• Walczak M, et al. The effect of fennel essential oil and trans-anethole on antibacterial activity of mupirocin against Staphylococcus aureus. PMC. 2019.
• Antimicrobial and antioxidant activities of fennel oil. PMC. 2023.
• Comparison of the Effect of Fennel and Evening Primrose Oil on Menopausal Problems and Hormonal Levels: A Randomized Controlled Trial. PMC. 2023.
• Ghazanfarpour M, et al. A double-blind, placebo-controlled trial of Fennel (Foeniculum vulgare) on menopausal symptoms: A high placebo response. PMC. 2018.
• Effect of the Mixed Herbal Medicines Extract (Fennel, Chamomile, and Saffron) on Menopause Syndrome: a Randomized Controlled Clinical Trial. PMC. 2019.
• Yaralizadeh M, et al. Effect of Foeniculum vulgare (fennel) vaginal cream on vaginal atrophy in postmenopausal women: A double-blind randomized placebo-controlled trial. Maturitas. 2016. PubMed.
• Pediatric gut-brain nutraceuticals review including fennel. PMC. 2024.
• Fennel Tea Has a Region-Specific Effect on the Motility of the Stomach. PMC. 2025.
• In vitro toxicity evaluation of estragole-containing preparations derived from Foeniculum vulgare Mill. (fennel) on HepG2 cells. ScienceDirect. 2018.
• EFSA. Protocol for the Scientific Opinion on the evaluation of the safety in use of preparations from the fruits of sweet and bitter fennel. EFSA Supporting Publications. 2023.
• European Medicines Agency (EMA) HMPC. Public statement on the use of herbal medicinal products containing estragole. EMA/HMPC/137212/2005.
• UK Committee on Toxicity: Introduction and Background — EFSA Opinion on safety of preparations from fruits of sweet and bitter fennel.
• Foeniculum vulgare as Valuable Plant in Management of Women's Health — Review Article. KoreaMed. 2019.
• American Herbal Products Association. Herbs in History: Fennel.
• McCormick Science Institute. Fennel — Culinary Spices Research Summary.
• Evaluation of the Essential Oil of Foeniculum vulgare Mill (Fennel) Fruits Extracted by Three Different Extraction Methods by GC/MS. PMC. 2014.
• Cardiovascular Effects, Phytochemistry, Drug Interactions, and Safety Profile of Foeniculum vulgare Mill. (Fennel): A Comprehensive Review. PMC. 2025.
• Drugs.com Natural Product Monograph: Fennel. 2025.